• At the therapeutic level the logical approach

  2019-07-02

  

  At the therapeutic level, the logical approach to address the cooperation between FGFR4 and EGFR was the combined inhibition of both receptors. To explore the potential efficacy and specificity of this approach, we tested the effect of FGFR and EGFR inhibitors in monotherapy or in combination in syn

• An intriguing feature of the pre and postsynaptic processes

  2019-07-02

  

  An intriguing feature of the pre and postsynaptic processes at the level of the VTA that have been shown to be mediated by CRF2 receptors [9], [34] is that they are exerted only by agonists with high affinity for both CRF2 receptors and CRF-BP. The four endogenous peptides of the CRF system have hig

• Stable isotope studies applied to skeletal remains of

  2019-07-02

  

  Stable isotope studies, applied to skeletal remains of early Pacific populations, have shown a trend toward a horticultural diet with temporal variation in response to local environmental conditions (Field et al., 2009; Kinaston and Buckley, 2013; Valentin et al., 2010, Valentin et al., 2014; Kinast

• br Methods br Results br Discussion There are

  2019-07-02

  

  Methods Results Discussion There are two particularly important facets of the present ERK findings relevant to drug conditioning. One is the strong ERK signal observed in the medial prefrontal cortex and the nucleus accumbens during the immediate post-trial interval following the final con

• In our previous research we have focused on the discovery

  2019-07-02

  

  In our previous research, we have focused on the discovery of novel VEGFR-2 inhibitors as anti-angiogenesis agents. Numbers of biphenyl-aryl urea incorporated with salicylaldoxime including BPS-7 have been developed as potent and selective VEGFR-2 inhibitors (Fig. 3) [12], [13], [14], [15], [16], [1

• br Results br Discussion Many studies have shown

  2019-07-02

  

  Results Discussion Many studies have shown that intrinsic properties of the E2 enzyme govern the nature of the Ub modification, including both the multiplicity of the Ub modification and the specific YM 155 structure type in the case of polyubiquitin chains [3], [4], [9], [14]. Whereas previou

• br Conclusion In vivo pharmacokinetic studies

  2019-07-01

  

  Conclusion In vivo pharmacokinetic studies showed that dasatinib monohydrate pretreatment significantly decreased the blood level of CsA in rats, which was most probably due to the induction of CYP3A2 isoenzymes. The nilotinib pre-treatment had no significant effects on cyclosporine pharmacokinet

• The causes of POD are complex and not entirely

  2019-07-01

  

  The causes of POD are complex, and not entirely clear. Androsova et al, believed that the main molecular mechanism of POD is a central cholinergic deficiency caused by deregulation of cholinergic anti-inflammatory pathways leading to increased inflammation. The cholinergic anti-inflammatory pathway,

• The WHO guidance promotes pre exposure prophylaxis for all

  2019-07-01

  

  The 2016 WHO guidance promotes pre-exposure prophylaxis for all populations with an incidence of HIV above three per 100 person-years. This guidance is, some ways, an indictment on the promotion of condoms in HIV prevention. However, WHO does not retract its message regarding the use of condoms. The

• An early output of the Initiative is the

  2019-07-01

  

  An early output of the Initiative is the new WHO definition of maternal sepsis, which reads as follows: “Maternal sepsis is a life-threatening condition defined as organ dysfunction resulting from infection during pregnancy, child-birth, post-abortion, or post-partum period”. The new maternal sepsis

• br Conclusion br Conflict of interest br Introduction Classi

  2019-07-01

  

  Conclusion Conflict of interest Introduction Classically, cancer has been described as a disease involving uncontrolled cell growth. Now, however, it is apparent that cancer growth and metastasis are not solely dependent on the tumor vorapaxar weight themselves, but involve pathologies in t

• This trial included patients who met the ICD criteria

  2019-07-01

  

  This trial included 1500 patients, who met the ICD criteria for primary prevention (non-ischemic, ischemic, dual chamber ICD or CRT-D). The patients were randomized to 3 arms: (1) conventional therapy: Zone 1(VT) 170bpm, 2.5s delay, Zone 2 (VF) 200bpm, 1s delay; (2) high rate therapy: Zone 1(VT) 170

• br Cardiac imaging br Head up tilt

  2019-07-01

  

  Cardiac imaging Head-up tilt testing Head-up tilt (HUT) testing is recommended to judge an episode of syncope to be likely caused by VF by excluding neurally mediated syncope (NMS). However, NMS may coexist with Brugada syndrome [42]. We conducted HUT testing in 46 patients with type-1 Brugada

• The CONNECT trial conducted by Crossley et

  2019-07-01

  

  The CONNECT trial conducted by Crossley et al. [22] was also a multicenter, prospective, randomized evaluation of wireless RM, which included 1997 patients implanted with ICDs or CRT-Ds. They were randomly assigned to the remote or in-office groups and followed up for 15 months. The median time from

• fccp molecular The first variant in the non spine topic desc

  2019-07-01

  

  The first variant in the non-spine topic describes a patient with an excellent performance status, a favorable life expectancy, and an asymptomatic fccp molecular lesion which does not pose an obvious risk for pathologic fracture. While the authors acknowledge that research has begun to determine wh

15615 records 1007/1041 page Previous Next First page 上5页 10061007100810091010 下5页 Last page